Showing results (41-50 of 483) with videos related to

Sort By:
Pageof 49
Prostaglandins, Leukotrienes, and Essential Fatty Acids|October 1, 1989
Effects of taprostene, a chemically stable prostacyclin analogue, in patients with ischaemic peripheral vascular disease: a placebo controlled double-blind trialI Virgolini, P Fitscha, J O'Grady, et al.
Prostaglandins, Leukotrienes, and Essential Fatty Acids|April 1, 1992
The diminished extracellular matrix production induced by isradipine, a calcium channel blocker, is completely abolished by cyclooxygenase inhibitionP Fitscha, A Keiler, F Rauscha, et al.
Thrombosis Research|February 1, 1992
Modification of platelet function by isosorbide dinitrate in patients with coronary artery diseaseH Sinzinger, I Virgolini, J O'Grady, et al.
Folia Haematologica (Leipzig, Germany : 1928)|January 1, 1988
Platelet derived growth factor (PDGF) and prostaglandins (PGE1, PGI2) as modulators of the atherogenetic processH Sinzinger, T Zidek, P Fitscha, et al.
Prostaglandins, Leukotrienes, and Essential Fatty Acids|July 1, 1988
Epoprostenol in patients with Raynaud's diseaseP Fitscha, J Kaliman, F Weidinger, et al.
Prostaglandins|August 1, 1996
Prostaglandin I2-mediated upregulation of 125I-LDL-receptor binding by isradipine in normo- and hypercholesterolemic rabbits in vivoH Sinzinger, G Lupattelli, H Kritz, et al.
British Journal of Clinical Pharmacology|November 1, 1987
Development of optimal infusion regimens for epoprostenol using radio labelled platelet uptake over atherosclerotic lesions in manH Sinzinger, P Fitscha, J Kaliman, et al.
Platelets|November 4, 2010
Influence of a single dose of calcium channel blockers on platelet functionK Weiss, P Fitscha, I Virgolini, et al.
Lancet (London, England)|December 15, 1984
Detection of aneurysms by gamma-camera imaging after injection of autologous labelled plateletsH Sinzinger, J O'Grady, P Fitscha, et al.
Thrombosis Research|June 15, 1988
Comparable effect of prostaglandin E1 in decreasing in vivo platelet deposition on human lesion sites after intravenous and intraarterial applicationH Sinzinger, J O'Grady, P Fitscha, et al.
Pageof 49